To confirm the fibroblast heterogeneity in the OSA TME, we used fibroblast activation protein alpha (FAP) and actin alpha-2 (ACTA2; alpha-smooth muscle actin, α-SMA) as markers of fibroblasts. The gene discussed is FAP; the disease is obstructive sleep apnea syndrome.